Tourmaline Bio (TRML) Plunges 7.37% After Truist Cuts Price Target

Generado por agente de IAAinvest Movers Radar
jueves, 10 de abril de 2025, 6:28 pm ET1 min de lectura
TRML--

Tourmaline Bio (TRML) shares fell 3.01% today, reaching their lowest level since October 2023, with an intraday decline of 7.37%.

One of the primary factors influencing the stock price of Tourmaline BioTRML-- (TRML) is the recent adjustment of its price target by Truist. Truist lowered the price target from $74 to $63 while maintaining a Buy rating on the shares. This adjustment could influence investor perception and trading behavior, potentially impacting the stock price.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios